Biotech Acquisition Company (BIOT)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 02:25PM EDT
| Previous close | 9.90 |
| Open | 9.90 |
| Bid | 9.86 x 1100 |
| Ask | 9.90 x 1100 |
| Day's range | 9.88 - 9.90 |
| 52-week range | 8.30 - 10.41 |
| Volume | |
| Avg. volume | 142,701 |
| Market cap | 284.338M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Blade Therapeutics to Participate in "Drug Development in Pulmonary Medicine" Panel Discussion at 2022 BTIG Biotechnology Conference
SAN FRANCISCO, August 01, 2022--Blade Therapeutics to participate in "Drug Development in Pulmonary Medicine" panel discussion on August 9 at the 2022 BTIG Biotechnology Conference
- Business Wire
Blade Therapeutics Presents Preclinical Data Highlighting Differentiating Characteristics of Cudetaxestat at the American Thoracic Society 2022 International Conference
SOUTH SAN FRANCISCO, Calif., May 18, 2022--Blade Therapeutics announces new data from preclinical studies that highlight differentiating characteristics of cudetaxestat in poster at ATS 2022.
- Business Wire
Blade Therapeutics Presents Data from Phase 1 and Preclinical Studies of Cudetaxestat at the American Thoracic Society 2022 International Conference
SOUTH SAN FRANCISCO, Calif., May 16, 2022--Blade Therapeutics presented data from phase 1 & preclinical DDI studies of cudetaxestat at American Thoracic Society 2022 International Conference
© 2022 Yahoo. All rights reserved.
